Pediatric and Young Adult Image-Guided Percutaneous Bone Biopsy-A New Standard of Care?

Why This Matters

For decades, open surgical biopsy was the default for suspected pediatric bone tumors — a practice born from the need for adequate tissue and the fear of seeding the biopsy tract 0:56. That approach requires general anesthesia, leaves a scar, and commits the patient to an operating room and recovery period before treatment even begins 0:56. Image-guided percutaneous biopsy exists as an alternative because interventional radiology can now deliver a needle to bone under CT or fluoroscopic guidance with millimeter precision, obtaining diagnostic tissue through a puncture rather than an incision 0:22 0:28.

The Core Question

Can a needle biopsy performed by interventional radiology yield sufficient tissue to diagnose pediatric bone and soft tissue tumors, support the molecular studies that now guide treatment, and do so safely enough to replace open biopsy as standard practice? 0:56

How the Approach Works

The technique relies on cross-sectional imaging to plan and execute the biopsy 0:22. CT is the most common modality, sometimes combined with fluoroscopy or ultrasound depending on the lesion's location and the surrounding anatomy 0:22. Interventional radiologists perform the procedures 0:28. Nearly 90% of cases use core-needle technique rather than fine-needle aspiration 0:19, which matters because core samples preserve tissue architecture and provide enough material for ancillary studies 0:46.

The procedural goal is not simply to confirm malignancy but to obtain tissue adequate for the full diagnostic workup modern oncology demands 0:46 0:46. Histology alone no longer suffices 0:46. Risk stratification and targeted therapy selection now depend on immunohistochemistry and molecular profiling — techniques that require intact tissue in sufficient quantity 0:46 0:46. A biopsy that answers "Is this cancer?" but cannot support molecular studies forces a second procedure or compromises treatment planning 0:46 0:46.

The Evidence From This Series

A single institution reviewed 169 biopsies in 141 patients over ten years 0:13. The diagnostic yield was 97.9% 0:33. Only three patients required repeat biopsy 0:33. That figure matters because it addresses the central objection to percutaneous technique: that needles sample too little tissue or miss the diagnostic area entirely 0:56. A 97.9% success rate suggests that image guidance and core-needle technique together solve the sampling problem for the vast majority of cases 0:33 0:33.

Complications were rare 0:43. One patient developed transient sciatic nerve paresis, which resolved 0:40. The overall complication rate was 0.7% 0:43. For context, open biopsy carries risks inherent to any operation requiring general anesthesia, surgical dissection, and wound healing — none of which appear in this series' complication profile 0:43 0:56.

Crucially, the tissue obtained was sufficient not only for diagnosis but for immunostains and molecular studies 0:46. This is the practical test of adequacy in contemporary practice 0:46 0:46. A biopsy that provides a diagnosis but insufficient material for molecular profiling has failed part of its job 0:46 0:46.

What Remains Uncertain

This is a single-institution series 0:13. The interventional radiologists performing these biopsies work at a tertiary pediatric center and have developed expertise in this population 0:13 0:28. Whether community hospitals or general interventional radiology practices can replicate these results is unknown. The 97.9% diagnostic yield may reflect not just the technique but the operators 0:33.

The series does not report long-term outcomes — specifically, whether percutaneous biopsy affects local recurrence rates or overall survival compared to open biopsy. The theoretical concern about tract seeding has never been substantiated in large series, but this study does not directly address it.

Finally, the study does not specify which lesions or anatomic sites might still favor open biopsy. Not all bone tumors are equally accessible to a percutaneous approach, and some locations — particularly those near critical neurovascular structures — may warrant surgical exposure for safety.

When to Use This Approach

One of the discussants argues that image-guided percutaneous biopsy should be strongly considered the diagnostic modality of choice for pediatric bone and soft tissue tumors 0:56. The data support that position for centers with experienced interventional radiology teams 0:13 0:33 0:43. The approach is safe, yields diagnostic tissue in nearly all cases, provides material for molecular studies, and avoids the morbidity of open surgery 0:33 0:43 0:46 0:56.

For referring clinicians, the practical implication is straightforward: when imaging identifies a bone or soft tissue mass requiring tissue diagnosis, interventional radiology should be the first call, not the fallback after surgical consultation 0:56. The question is no longer whether percutaneous biopsy can work, but whether your institution has the radiologic expertise to make it work reliably 0:13 0:28 0:33. If it does, the patient avoids an operation 0:56. If it does not, the answer is to build that capability, not to default to open biopsy indefinitely 0:56.